ϟ
DOI: 10.1182/blood-2017-05-785246
¤ OpenAccess: Bronze
This work has “Bronze” OA status. This means it is free to read on the publisher landing page, but without any identifiable license.
Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
Ajai Chari,Attaya Suvannasankha,Joseph W. Fay,Bertrand Arnulf,Jonathan L. Kaufman,Jainulabdeen J. Ifthikharuddin,Brendan M. Weiss,Amrita Krishnan,Suzanne Lentzsch,Raymond L. Comenzo,Jianping Wang,Kerri Nottage,Christopher Chiu,Nushmia Z. Khokhar,Tahamtan Ahmadi,Sagar Lonial
Daratumumab
Pomalidomide
Dexamethasone
2017
Loading...
- MLA
- APA
- Chicago
- IEEE
- Harvard
- BibTeX
Cite this:
Generate Citation
“Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma” is a paper by Ajai Chari Attaya Suvannasankha Joseph W. Fay Bertrand Arnulf Jonathan L. Kaufman Jainulabdeen J. Ifthikharuddin Brendan M. Weiss Amrita Krishnan Suzanne Lentzsch Raymond L. Comenzo Jianping Wang Kerri Nottage Christopher Chiu Nushmia Z. Khokhar Tahamtan Ahmadi Sagar Lonial published in 2017. It has an Open Access status of “bronze”. You can read and download a PDF Full Text of this paper here.